Reducing injection burden has long been a priority in diabetes care. Now, a weekly, fixed-dose combination of basal insulin and a GLP-1 receptor agonist is one step closer to approval in Europe.
FITBOOK magazine on MSN
Insider Reveals the Biggest Misconception About the Weight-Loss Injection
The GLP-1 injection is seen as a shortcut to the desired weight. What many now consider a lifestyle drug is actually a prescription medication, with risks, side effects, and clear limits. In a FITBOOK ...
GLP-1 medications have rapidly become some of the most influential treatments for Type 2 diabetes and weight loss. As more people look into these prescriptions, there is growing curiosity about how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results